The transformative impact of AI-based algorithms on the health care industry offers both immense potential for improving medical outcomes and significant challenges related to bias and disparities. The unexpected discovery by radiologist Judy Gichoya, M.D., and her team that AI could predict a
In a groundbreaking advancement, researchers from Tsinghua University and Beijing Tsinghua Changgung Hospital have developed a new approach called ECG-LM (Electrocardiogram-Large Model) that significantly enhances the interpretation of electrocardiogram (ECG) data for diagnosing heart diseases.
In recent developments, a collaborative research team led by the University of Arizona College of Medicine – Tucson has discovered groundbreaking potential for an FDA-approved osteoporosis drug in the treatment of a rare genetic heart disease. The heart condition in question is dilated
Imagine unlocking a code that holds the secret to the myriad complexities of brain evolution and the onset of neurological diseases. This concept has come closer to reality with a pivotal study led by a Belgian research team, which delves deep into the genetic regulatory codes that control brain
In a groundbreaking study published in JAMA, researchers from Mass General Brigham have demonstrated the potential of artificial intelligence (AI) to revolutionize patient screening for clinical trials. The study, led by co-senior authors Samuel (Sandy) Aronson and Alexander Blood, focused on a
AI is revolutionizing precision and personalized oncology care by enabling more accurate diagnoses, predicting patient outcomes, and tailoring treatments to individual needs. Through advanced algorithms and machine learning, AI can analyze vast amounts of data, including medical records, genetic
